Heart Failure
Showing NaN - NaN of 92
Randomized Ablation-based AF Rhythm-control Versus Rate-control
Not yet recruiting
- Atrial Fibrillation
- Heart Failure
-
Porto Alegre, Brazil
- +17 more
Apr 6, 2022
The Product Surveillance Registry REVERSE Post Approval Study
Active, not recruiting
- Heart Failure
-
Birmingham, Alabama
- +122 more
Feb 4, 2022
Heart Failure Trial in Montréal (Cognitive training, Usual Care)
Not yet recruiting
- Heart Failure
- Cognitive training
- Usual Care
-
Montréal, Quebec, Canada
- +1 more
Jan 31, 2022
Attain Performa™ Left Ventricular Quadripolar Leads Chronic
Completed
- Heart Failure
-
Birmingham, Alabama
- +99 more
Jan 28, 2022
Heart Failure, Myocardial Infarction Trial in Canada, Puerto Rico, United States (High Dose Trivalent Influenza Vaccine,
Completed
- Heart Failure
- Myocardial Infarction
- High Dose Trivalent Influenza Vaccine
- Standard Dose Quadrivalent Influenza Vaccine
-
Birmingham, Alabama
- +189 more
Dec 22, 2021
Heart Failure, Iron-deficiency Trial in Worldwide (Ferric Carboxymaltose, Placebo)
Active, not recruiting
- Heart Failure
- Iron-deficiency
- Ferric Carboxymaltose
- Placebo
-
Alexander City, Alabama
- +345 more
Nov 12, 2021
Heart Failure Trial in Worldwide (Omecamtiv Mecarbil, Placebo, Standard of Care)
Completed
- Heart Failure
- Omecamtiv Mecarbil
- +2 more
-
Birmingham, Alabama
- +1033 more
Nov 2, 2021
Heart Failure Trial in Worldwide (MPP)
Terminated
- Heart Failure
- MPP
-
Huntsville, Alabama
- +205 more
Oct 28, 2021
Heart Failure, Anemia, Cardiovascular Disease Trial in Worldwide (Darbepoetin alfa, Placebo)
Completed
- Heart Failure
- +4 more
- Darbepoetin alfa
- Placebo
-
Birmingham, Alabama
- +753 more
Oct 31, 2021
Heart Failure, Atrial Fibrillation Trial in Worldwide (Rhythm control, Rate Control)
Completed
- Heart Failure
- Atrial Fibrillation
- Rhythm control
- Rate Control
-
Porto Alegre, Rio Grande Do Sul, Brazil
- +20 more
Oct 13, 2021
Cardiac Mechanics, Biomarkers and Frailty in Aortic Stenosis
Recruiting
- Heart Failure
- Aortic Stenosis
- Observational only
-
Montreal, Quebec, CanadaMontreal Heart Institute
Aug 30, 2021
Heart Failure Trial in Worldwide (Placebo, Omecamtiv mecarbil)
Completed
- Heart Failure
- Placebo
- Omecamtiv mecarbil
-
Mobile, Alabama
- +149 more
Jul 25, 2021
Sleep Apnea, Heart Failure Trial in Worldwide (Adaptive Servo Ventilation)
Terminated
- Sleep Apnea
- Heart Failure
- Adaptive Servo Ventilation
-
Tucson, Arizona
- +48 more
Jul 9, 2021
Heart Failure Trial in Vancouver, Toronto, Montreal (eCounseling + Usual Care)
Completed
- Heart Failure
- eCounseling + Usual Care
-
Vancouver, British Columbia, Canada
- +2 more
Jun 30, 2021
Heart Failure Trial in Worldwide (Finerenone (BAY94-8862), Placebo, Inspra (eplerenone))
Completed
- Heart Failure
- Finerenone (BAY94-8862)
- +2 more
-
Birmingham, Alabama
- +171 more
Jul 2, 2021
Heart Failure Trial in Worldwide (Sodium Zirconium Cyclosilicate, Placebo)
Terminated
- Heart Failure
- Sodium Zirconium Cyclosilicate
- Placebo
-
National City, California
- +75 more
May 20, 2021
Heart Failure Trial in Worldwide (Empagliflozin, Placebo)
Heart Failure, Motivation Trial in Montreal (SIGN@L-A, SIGN@L-B)
Completed
- Heart Failure
- Motivation
- SIGN@L-A
- SIGN@L-B
-
Montreal, Quebec, CanadaUniversité de Montréal
Apr 26, 2021
Heart Failure Trial in Worldwide (Vericiguat (BAY1021189) (1.25 mg), Vericiguat (BAY1021189) (5 mg), Placebo)
Completed
- Heart Failure
- Vericiguat (BAY1021189) (1.25 mg)
- +2 more
-
Fountain Valley, California
- +156 more
Mar 2, 2021
Heart Failure Trial in Worldwide (Vericiguat (BAY1021189) (1.25 mg), Vericiguat (BAY1021189) (5 mg), Placebo)
Completed
- Heart Failure
- Vericiguat (BAY1021189) (1.25 mg)
- +2 more
-
Fountain Valley, California
- +157 more
Feb 25, 2021
Heart Failure Trial in Worldwide (Cardiac Resynchronization Therapy - MPP)
Completed
- Heart Failure
- Cardiac Resynchronization Therapy - MPP
-
Birmingham, Alabama
- +77 more
Feb 15, 2021
Model 4396 Left Ventricular (LV) Lead Chronic Performance Study
Completed
- Heart Failure
-
Gilbert, Arizona
- +51 more
Feb 15, 2021
Optisure Lead Post Approval Study
Terminated
- Heart Failure
- Tachycardia, Ventricular
- St. Jude Medical Optisure Lead
-
Birmingham, Alabama
- +59 more
Jan 13, 2021
Sodium-glucose Cotransporter 2 Inhibitors and Risk of
Completed
- Type2 Diabetes
- +5 more
- Sodium-glucose cotransporter 2 (SGLT2) inhibitors
- Dipeptidyl peptidase-4 (DPP-4) inhibitors
-
Montreal, Quebec, CanadaLady Davis Institute for Medical Research, Jewish General Hospit
Oct 1, 2020